Area of research
Oncology · Radiology, Nuclear Medicine and Imaging
Research interest
Research focused on KRAS and Clinical endpoint, with related work in Breast cancer, Mutation, Hazard ratio. Notable publications include 'Glecirasib in KRASG12C-mutated nonsmall-cell lung cancer: a phase 2b trial', 'A pivotal phase 2 single-arm study of glecirasib (JAB-21822) in patients with NSCLC harboring KRAS G12C mutation', and 'Impact of HER2-low status for patients with early-stage breast cancer and non-pCR after neoadjuvant chemotherapy: a National Cancer Database Analysis'.